• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非酒精性脂肪性肝炎模型中,M2巨噬细胞衍生的外泌体微小RNA-411-5p通过靶向CAMSAP1抑制肝星状细胞的激活。

M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model.

作者信息

Wan Zhiping, Yang Xiaoan, Liu Xiaoquan, Sun Yinfang, Yu Piaojian, Xu Fen, Deng Hong

机构信息

Department of Infectious Diseases, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.

Guangdong Provincial Key Laboratory of Diabetology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China.

出版信息

iScience. 2022 Jun 14;25(7):104597. doi: 10.1016/j.isci.2022.104597. eCollection 2022 Jul 15.

DOI:10.1016/j.isci.2022.104597
PMID:35789846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9249826/
Abstract

Liver fibrosis is a severe stage of nonalcoholic fatty liver disease (NAFLD), which is closely associated with the activation of hepatic stellate cells (HSCs) and their interaction with macrophages. Exosomes can mediate crosstalk between macrophages and HSCs in NAFLD-associated fibrosis. We found that M2 macrophage-derived exosomes significantly inhibit HSCs activation. RNA-seq studies revealed that miRNA-411-5p was decreased in serum exosomes of nonalcoholic steatohepatitis (NASH) patients as compared with that in healthy controls. Besides, miR-411-5p and M2 macrophage markers are decreased in the liver of the NASH model. We further proved that exosomal miR-411-5p from M2 macrophages inhibit HSCs activation and miR-411-5p directly downregulated the expression of Calmodulin-Regulated Spectrin-Associated Protein 1 () to inactivate stellate cells. Importantly, knockdown of also inhibited HSCs activation. This study contributes to understanding the underlying mechanism of HSCs activation and indicates may serve as a potential therapeutic target for NASH.

摘要

肝纤维化是非酒精性脂肪性肝病(NAFLD)的严重阶段,与肝星状细胞(HSCs)的激活及其与巨噬细胞的相互作用密切相关。外泌体可介导NAFLD相关纤维化中巨噬细胞与HSCs之间的串扰。我们发现M2巨噬细胞衍生的外泌体显著抑制HSCs激活。RNA测序研究表明,与健康对照相比,非酒精性脂肪性肝炎(NASH)患者血清外泌体中的miRNA-411-5p减少。此外,NASH模型肝脏中miR-411-5p和M2巨噬细胞标志物减少。我们进一步证明,M2巨噬细胞的外泌体miR-411-5p抑制HSCs激活,且miR-411-5p直接下调钙调蛋白调节的血影蛋白相关蛋白1()的表达以使星状细胞失活。重要的是,敲低也抑制HSCs激活。本研究有助于理解HSCs激活的潜在机制,并表明可能作为NASH的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/ca42ce3dea55/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/001cea3a1bc4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/9830a7ab033e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/3d9be1125d2e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/d6e9f1606a0b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/b181a1e3ff1f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/47f291f3388f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/ca42ce3dea55/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/001cea3a1bc4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/9830a7ab033e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/3d9be1125d2e/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/d6e9f1606a0b/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/b181a1e3ff1f/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/47f291f3388f/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a82f/9249826/ca42ce3dea55/gr6.jpg

相似文献

1
M2 macrophage-derived exosomal microRNA-411-5p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model.在非酒精性脂肪性肝炎模型中,M2巨噬细胞衍生的外泌体微小RNA-411-5p通过靶向CAMSAP1抑制肝星状细胞的激活。
iScience. 2022 Jun 14;25(7):104597. doi: 10.1016/j.isci.2022.104597. eCollection 2022 Jul 15.
2
Lipotoxic Hepatocyte-Derived Exosomal MicroRNA 192-5p Activates Macrophages Through Rictor/Akt/Forkhead Box Transcription Factor O1 Signaling in Nonalcoholic Fatty Liver Disease.脂毒性肝细胞衍生的外泌体 microRNA-192-5p 通过 Rictor/Akt/Forkhead Box 转录因子 O1 信号通路激活非酒精性脂肪性肝病中的巨噬细胞。
Hepatology. 2020 Aug;72(2):454-469. doi: 10.1002/hep.31050. Epub 2020 May 16.
3
MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.微小RNA-146a-5p通过直接靶向Wnt1和Wnt5a抑制非酒精性纤维化脂肪性肝炎中肝星状细胞的激活和增殖。
Sci Rep. 2015 Nov 5;5:16163. doi: 10.1038/srep16163.
4
Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells.脂多糖激活的 THP-1 巨噬细胞来源的外泌体 miR-103-3p 促进肝星状细胞的活化。
FASEB J. 2020 Apr;34(4):5178-5192. doi: 10.1096/fj.201902307RRR. Epub 2020 Feb 15.
5
Hepatocyte-derived exosomal miR-146a-5p inhibits hepatic stellate cell EMT process: a crosstalk between hepatocytes and hepatic stellate cells.肝细胞衍生的外泌体miR-146a-5p抑制肝星状细胞上皮-间质转化过程:肝细胞与肝星状细胞之间的相互作用
Cell Death Discov. 2023 Aug 19;9(1):304. doi: 10.1038/s41420-023-01602-y.
6
Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.由 miR-181-5p 修饰的脂肪间充质干细胞衍生的外泌体通过自噬激活预防肝纤维化。
J Cell Mol Med. 2017 Oct;21(10):2491-2502. doi: 10.1111/jcmm.13170. Epub 2017 Apr 6.
7
Inhibition of miR-188-5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway.miR-188-5p 的抑制通过 PTEN/PI3K/AKT 通路显著减少 HSCs 的活化和增殖,从而减轻肝纤维化。
J Cell Mol Med. 2021 Apr;25(8):4073-4087. doi: 10.1111/jcmm.16376. Epub 2021 Mar 10.
8
Phillygenin inhibited M1 macrophage polarization and reduced hepatic stellate cell activation by inhibiting macrophage exosomal miR-125b-5p.汉防己甲素通过抑制巨噬细胞外泌体 miR-125b-5p 抑制 M1 型巨噬细胞极化并减少肝星状细胞激活。
Biomed Pharmacother. 2023 Mar;159:114264. doi: 10.1016/j.biopha.2023.114264. Epub 2023 Jan 16.
9
DHFR silence alleviated the development of liver fibrosis by affecting the crosstalk between hepatic stellate cells and macrophages.DHFR 沉默通过影响肝星状细胞和巨噬细胞之间的串扰来减轻肝纤维化的发展。
J Cell Mol Med. 2021 Nov;25(21):10049-10060. doi: 10.1111/jcmm.16935. Epub 2021 Oct 9.
10
Fibrogenic Signaling Is Suppressed in Hepatic Stellate Cells through Targeting of Connective Tissue Growth Factor (CCN2) by Cellular or Exosomal MicroRNA-199a-5p.通过细胞或外泌体微小RNA-199a-5p靶向结缔组织生长因子(CCN2),肝星状细胞中的纤维化信号传导受到抑制。
Am J Pathol. 2016 Nov;186(11):2921-2933. doi: 10.1016/j.ajpath.2016.07.011. Epub 2016 Sep 21.

引用本文的文献

1
Monocytes and Macrophages as Unique Cellular Compartments Governing Non-Alcoholic Fatty Liver Disease and Inflammation.单核细胞和巨噬细胞作为调控非酒精性脂肪性肝病和炎症的独特细胞区室
Avicenna J Med Biotechnol. 2025 Apr-Jun;17(2):98-105. doi: 10.18502/ajmb.v17i2.18560.
2
The Immune Microenvironment: New Therapeutic Implications in Organ Fibrosis.免疫微环境:器官纤维化中的新治疗意义
Adv Sci (Weinh). 2025 Aug;12(30):e05067. doi: 10.1002/advs.202505067. Epub 2025 May 20.
3
Molecular Landscape and Diagnostic Model of MASH: Transcriptomic, Proteomic, Metabolomic, and Lipidomic Perspectives.

本文引用的文献

1
HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.HIF-1α 激活的长非编码 RNA KDM4A-AS1 通过 miR-411-5p/KPNA2/AKT 通路促进肝细胞癌进展。
Cell Death Dis. 2021 Dec 13;12(12):1152. doi: 10.1038/s41419-021-04449-2.
2
Liver fibrosis: Extracellular vesicles mediated intercellular communication in perisinusoidal space.肝纤维化:细胞外囊泡介导的窦周间隙中的细胞间通讯
Hepatology. 2022 Jul;76(1):275-285. doi: 10.1002/hep.32239. Epub 2021 Dec 18.
3
Exosomal miR-500 Derived From Lipopolysaccharide-Treated Macrophage Accelerates Liver Fibrosis by Suppressing MFN2.
代谢相关脂肪性肝病的分子图谱与诊断模型:转录组学、蛋白质组学、代谢组学和脂质组学视角
Genes (Basel). 2025 Mar 29;16(4):399. doi: 10.3390/genes16040399.
4
Intestinal bacteria-derived extracellular vesicles in metabolic dysfunction-associated steatotic liver disease: From mechanisms to therapeutics.代谢功能障碍相关脂肪性肝病中肠道细菌衍生的细胞外囊泡:从机制到治疗
Mol Cells. 2025 Jun;48(6):100216. doi: 10.1016/j.mocell.2025.100216. Epub 2025 Apr 14.
5
Roles of extracellular vesicles from different origins in metabolic-associated fatty liver disease: progress and perspectives.不同来源的细胞外囊泡在代谢相关脂肪性肝病中的作用:进展与展望
Front Immunol. 2025 Mar 10;16:1544012. doi: 10.3389/fimmu.2025.1544012. eCollection 2025.
6
Extracellular Vesicles and Micro-RNAs in Liver Disease.肝病中的细胞外囊泡与微小RNA
Semin Liver Dis. 2025 Jun;45(2):167-179. doi: 10.1055/a-2494-2233. Epub 2024 Dec 3.
7
Extracellular Vesicles in Viral Liver Diseases.细胞外囊泡在病毒性肝病中的作用。
Viruses. 2024 Nov 17;16(11):1785. doi: 10.3390/v16111785.
8
CXCL11 reprograms M2-biased macrophage polarization to alleviate pulmonary fibrosis in mice.趋化因子CXCL11重编程M2偏向性巨噬细胞极化以减轻小鼠肺纤维化。
Cell Biosci. 2024 Nov 15;14(1):140. doi: 10.1186/s13578-024-01320-7.
9
Novel insights into the role of immunomodulatory extracellular vesicles in the pathogenesis of liver fibrosis.免疫调节性细胞外囊泡在肝纤维化发病机制中的作用的新见解。
Biomark Res. 2024 Oct 12;12(1):119. doi: 10.1186/s40364-024-00669-8.
10
Sinusoidal communication in chronic liver disease.慢性肝病中的窦状隙通讯
Clin Mol Hepatol. 2025 Jan;31(1):32-55. doi: 10.3350/cmh.2024.0734. Epub 2024 Oct 2.
源自脂多糖处理巨噬细胞的外泌体miR-500通过抑制MFN2加速肝纤维化
Front Cell Dev Biol. 2021 Oct 5;9:716209. doi: 10.3389/fcell.2021.716209. eCollection 2021.
4
Sparcl1 promotes nonalcoholic steatohepatitis progression in mice through upregulation of CCL2.Sparcl1 通过上调 CCL2 促进小鼠非酒精性脂肪性肝炎的进展。
J Clin Invest. 2021 Oct 15;131(20). doi: 10.1172/JCI144801.
5
Hepatic stellate cell-derived exosomes modulate macrophage inflammatory response.肝星状细胞衍生的外泌体调节巨噬细胞炎症反应。
Exp Cell Res. 2021 Aug 1;405(1):112663. doi: 10.1016/j.yexcr.2021.112663. Epub 2021 May 26.
6
Hepatic macrophages: Key players in the development and progression of liver fibrosis.肝脏巨噬细胞:肝纤维化发生和发展中的关键角色。
Liver Int. 2021 Oct;41(10):2279-2294. doi: 10.1111/liv.14940. Epub 2021 May 24.
7
Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease.脂毒性肝细胞来源的外泌体miR-1297通过PTEN信号通路促进代谢相关脂肪性肝病中肝星状细胞的激活。
World J Gastroenterol. 2021 Apr 14;27(14):1419-1434. doi: 10.3748/wjg.v27.i14.1419.
8
Hepatic Stellate Cell Activation and Inactivation in NASH-Fibrosis-Roles as Putative Treatment Targets?非酒精性脂肪性肝炎-肝纤维化中肝星状细胞的激活与失活——作为潜在治疗靶点的作用?
Biomedicines. 2021 Mar 31;9(4):365. doi: 10.3390/biomedicines9040365.
9
The Target MicroRNAs and Potential Underlying Mechanisms of Yiqi-Bushen-Tiaozhi Recipe against-Non-Alcoholic Steatohepatitis.益气补肾调脂方抗非酒精性脂肪性肝炎的靶向微小RNA及潜在机制
Front Pharmacol. 2020 Nov 12;11:529553. doi: 10.3389/fphar.2020.529553. eCollection 2020.
10
Myeloid-Cell-Specific IL-6 Signaling Promotes MicroRNA-223-Enriched Exosome Production to Attenuate NAFLD-Associated Fibrosis.髓系细胞特异性 IL-6 信号促进富含 microRNA-223 的外泌体产生,从而减轻非酒精性脂肪性肝病相关纤维化。
Hepatology. 2021 Jul;74(1):116-132. doi: 10.1002/hep.31658. Epub 2021 Apr 27.